Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers

被引:147
作者
Pauwels, R
Newman, S
Borgstrom, L
机构
[1] PHARMACEUT PROFILES LTD, NOTTINGHAM, ENGLAND
[2] ASTRO DRACO AB, LUND, SWEDEN
[3] UPPSALA UNIV, DEPT BIOPHARM, UPPSALA, SWEDEN
关键词
airway deposition; asthma; bronchodilator; dry powder inhaler; glucocorticosteroid; metered-dose inhaler;
D O I
10.1183/09031936.97.10092127
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Many different metered-dose inhalation devices are becoming available for the treatment of airway diseases, Each of these inhalers differs in its delivery characteristics. An assessment of the efficacy of drug delivery by these inhalers is essential, in view of their therapeutic use. A review of the literature on the relationship between airway deposition and airway effects of drugs delivered from metered-dose inhalers is presented, Nebulizers or spacers are not discussed, The effect of an inhaler depends on the characteristics of the inhaler and the inhalation manoeuvre performed by the patient, This review focuses on the influence of inhaler characteristics on the airway deposition and airway effects. Data from several studies show that there is a significant relationship between the amount of drug deposited in the airways and the airway effects of the drug. Studies on the relationship between airway deposition and airway effect have been troubled by methodological problems, such as the absence of multiple dose comparisons and the difficulty in obtaining steep dose-response curves, The techniques for measuring airway deposition of inhaled drugs, namely the scintigraphic and the pharmacokinetic method, are discussed and compared, The appropriate use of these techniques can help to define and compare the drug delivery characteristics of different devices, thus enabling inhaled therapy to be optimized.
引用
收藏
页码:2127 / 2138
页数:12
相关论文
共 106 条
[1]   IMPORTANCE OF THE INHALATION DEVICE ON THE EFFECT OF BUDESONIDE [J].
AGERTOFT, L ;
PEDERSEN, S .
ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 69 (01) :130-133
[2]   CHARACTERIZING LUNG AEROSOL PENETRATION [J].
AGNEW, JE .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1991, 4 (03) :237-249
[3]  
AMY R, 1987, BR J DIS CHEST, V81, P371
[4]   DRY POWDER AEROSOLS .1. NEW POWDER INHALATION DEVICE [J].
BELL, JH ;
HARTLEY, PS ;
COX, JSG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (10) :1559-&
[5]   IN-VITRO PROPERTIES OF PRESSURIZED METERED-DOSE INHALERS WITH AND WITHOUT SPACER DEVICES [J].
BERG, E .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1995, 8 :S3-S11
[6]   THE LUNG DEPOSITION OF SALBUTAMOL, DIRECTLY LABELED WITH TC-99M, DELIVERED BY PRESSURIZED METERED-DOSE AND DRY POWDER INHALERS [J].
BIDDISCOMBE, MF ;
MELCHOR, R ;
MAK, VHF ;
MARRIOTT, RJ ;
TAYLOR, AJ ;
SHORT, MD ;
SPIRO, SG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 91 (2-3) :111-121
[7]   PULMONARY DEPOSITION OF INHALED TERBUTALINE - COMPARISON OF SCANNING GAMMA-CAMERA AND URINARY-EXCRETION METHODS [J].
BORGSTROM, L ;
NEWMAN, S ;
WEISZ, A ;
MOREN, F .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (08) :753-755
[8]   A METHOD FOR DETERMINATION OF THE ABSOLUTE PULMONARY BIOAVAILABILITY OF INHALED DRUGS - TERBUTALINE [J].
BORGSTROM, L ;
NILSSON, M .
PHARMACEUTICAL RESEARCH, 1990, 7 (10) :1068-1070
[9]   The inhalation device influences lung deposition and bronchodilating effect of terbutaline [J].
Borgstrom, L ;
Derom, E ;
Stahl, E ;
WahlinBoll, E ;
Pauwels, R .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (05) :1636-1640
[10]   TOTAL AND REGIONAL LUNG DEPOSITION OF TERBUTALINE SULFATE INHALED VIA A PRESSURIZED MDI OR VIA TURBUHALER (R) [J].
BORGSTROM, L ;
NEWMAN, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 97 (1-3) :47-53